
Johnson & Johnson Highlights TECNIS PureSee IOL Data Showing Enhanced Vision at ASCRS 2026
Johnson & Johnson Presents New TECNIS PureSee IOL Clinical Data Showing Strong Contrast Sensitivity and Extended Vision Range at ASCRS 2026 Johnson & Johnson (NYSE: JNJ) has announced the presentation…












